Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
- PMID: 37892015
- PMCID: PMC10605768
- DOI: 10.3390/diagnostics13203194
Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
Abstract
We investigated the reference intervals for Apolipoprotein B (ApoB), a valuable biomarker for cardiovascular diseases, in Korean adults who had undergone health check-ups and showed normal lipid levels under traditional lipid tests, including total cholesterol, triglyceride, and high-density lipoprotein cholesterol, along with ApoB. We compared the findings with different cutoffs for ApoB from international clinical guidelines. Among a total of 264,105 traditional lipid test sets, only 464 (0.2%) included ApoB tests, indicating underutilization of this test in health check-up clinics in Korea. From these 464 samples, 334 ApoB results (164 men and 170 women) with normal traditional lipid test results were used to establish reference intervals. Using the parametric method (mean ± 2 SD), the reference intervals ranged from 46 to 134 mg/dL for men and 49 to 129 mg/dL for women. Employing the non-parametric method (central 95th percentile value), the reference intervals ranged from 50 to 131 mg/dL for men and 51 to 127 mg/dL for women. The prevalence of high ApoB did not significantly differ by sex when considering the established reference intervals for each sex and the cutoffs recommended by international clinical guidelines. This study enhances knowledge on ApoB reference intervals in the Korean population, and it will in aid test result interpretation for clinicians and laboratories.
Keywords: ApoB; Korean; apolipoprotein B; dyslipidemia; lipid; reference interval.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population.Metabolites. 2024 Mar 18;14(3):169. doi: 10.3390/metabo14030169. Metabolites. 2024. PMID: 38535329 Free PMC article.
-
Development and Validation of Multiple Equations for Low-Density Lipoprotein and Apolipoprotein B in Korean Patients Visiting Local Clinics and Hospitals.Nutrients. 2023 Jun 17;15(12):2786. doi: 10.3390/nu15122786. Nutrients. 2023. PMID: 37375689 Free PMC article.
-
Assessment of apoB dyslipoproteinemia in Korean population.Clin Biochem. 2013 Aug;46(12):1041-1046. doi: 10.1016/j.clinbiochem.2013.05.042. Epub 2013 May 15. Clin Biochem. 2013. PMID: 23685223
-
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.J Am Heart Assoc. 2023 Aug;12(15):e030405. doi: 10.1161/JAHA.123.030405. Epub 2023 Jul 25. J Am Heart Assoc. 2023. PMID: 37489721 Free PMC article. Review.
-
Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.Am J Cardiol. 2012 Nov 15;110(10):1468-76. doi: 10.1016/j.amjcard.2012.07.007. Epub 2012 Aug 17. Am J Cardiol. 2012. PMID: 22906895 Review.
Cited by
-
Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population.Metabolites. 2024 Mar 18;14(3):169. doi: 10.3390/metabo14030169. Metabolites. 2024. PMID: 38535329 Free PMC article.
References
-
- Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. - DOI - PMC - PubMed
-
- Grundy S.M., Stone N.J., Bailey A.L., Beam C., Birtcher K.K., Blumenthal R.S., Braun L.T., de Ferranti S., Faiella-Tommasino J., Forman D.E., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–e1143. - PMC - PubMed
-
- Pearson G.J., Thanassoulis G., Anderson T.J., Barry A.R., Couture P., Dayan N., Francis G.A., Genest J., Grégoire J., Grover S.A., et al. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can. J. Cardiol. 2021;37:1129–1150. doi: 10.1016/j.cjca.2021.03.016. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous